According to Coherent Market Insights, the global neuroimaging market size is calculated at 37.63 billion in 2023 and is projected to surpass USD 56.58 billion by 2030 with a remarkable CAGR of 6% from 2023 to 2030.
Market Dynamics: Rising prevalence of neurological disorders and growing demand for
accurate diagnosis drive market growth. According to the WHO, neurological
disorders affect over 1 billion people globally with Parkinson disease and
Alzheimer disease. The surge in neurological disorders has increased the demand
for accurate diagnostic techniques like MRI, CT scans.
Technological advancements in neuroimaging modalities also drives
market growth. It supports high resolution images, driving its adoption. However,
high costs associated neuroimaging procedures hinders market growth. Request Sample Copy of the Report @ https://www.coherentmarketinsights.com/insight/request-sample/6384
Market Trends: Integration of artificial intelligence with neuroimaging is a key
trend driving market growth. AI assists in automated image analysis, detection
of anomalies in MRI and CT scan images. Anthropic has developed an AI-based
tool, Clara. This tool analyses neuroimaging scans and detects abnormalities in
the brain. Another key trend gaining traction is demand for mobile and wearable
neuroimaging devices. Demand for portable diagnostic solutions at home care
settings has led to development of compact neuroimaging devices. Companies are
focusing on designing wearable EEG monitoring devices and portable MRI
machines. General Electric has developed a portable MRI machine suitable for
operation in ambulances and emergency rooms. Neuroimaging Market Report Coverage Report Coverage Details Market Revenue in 2023 $37.63 billion Estimated Value by 2030 $56.58 billion Growth Rate Poised to grow at a CAGR of 6% Historical Data 2018–2022 Forecast Period 2023–2030 Forecast Units Value (USD Million/Billion) Report Coverage Revenue Forecast, Competitive Landscape,
Growth Factors, and Trends Segments Covered By Technology, By Application, By End User Geographies Covered North America, Europe, Asia Pacific, and
Rest of World Growth Drivers • Advancements in Imaging Technology • Growing Prevalence of Neurological
Disorders Restraints & Challenges • High Equipment Costs • Limited Accessibility • Complexity of Data Interpretation
Market Opportunities: FMRI is expected to witness significant growth over the forecast
period. It uses magnetic fields and radio waves to produce cross-sectional
images of the brain. FMRI has revolutionized the field of cognitive
neuroscience. This enables non-invasive functional brain mapping in vivo. Immediate
Delivery Available | Buy This Premium Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/6384
The growing applications of fMRI in clinical diagnosis, drug
development and cognitive neuroscience are expected to propel the growth of
this segment. Positron Emission Tomography (PET) segment will drive the demand for
neuroimaging market. PET imaging uses radiotracers to depict metabolic
processes in the brain like neuroreceptor binding or glucose metabolism. PET has benefits over anatomical MRI as it provides functional or
molecular information. The use of novel radiotracers and hybrid PET systems is
driving the market. Limited availability and higher costs compared to other
techniques restricts widespread use of PET. Advances in scanner technologies to
improve quantification and multi-modality imaging integration can help overcome
these limitations. Key Market Takeaways The global neuroimaging market is anticipated to witness a CAGR of
6% during the forecast period 2024-2030. This is owing to the growing geriatric
population and rising prevalence of neurological disorders. On the basis of imaging type, the functional Magnetic Resonance
Imaging (fMRI) segment is expected to hold a dominant position. This is owing
to its non-invasive nature and widespread research applications. On the basis of end user, the hospitals segment is expected to hold
the largest share over the forecast period. This is due to availability of
advanced imaging facilities and trained professionals. North America is expected to hold a dominant position over the
forecast period. This is due to supportive government initiatives and higher
spending on neurological research. Competitor Insights - Siemens - Canon - Hitachi Medical Systems - General Electric Recent Developments: In November 2020, Siemens Healthineers launched the Magnetom
Free.Max. It is high-field MRI system which is more efficient and user-friendly
than traditional MRI systems. In April 2022, GE Healthcare launched its next generation revolution
aspire computer tomography (CT) scanner. This CT system is equipped with higher
imagining intelligence. Ask For
Customization @ https://www.coherentmarketinsights.com/insight/request-customization/6384
Neuroimaging Market
Segmentation: By Technology: By Application: By End User: By Region: Find Most Trending Related Reports: The global medical
imaging equipment market is
estimated to be valued at US$ 45.0 billion in 2023 and is expected to exhibit a
CAGR of 5.3% during the forecast period (2023-2030). The global neurology
monitoring market was valued
at US$ 5,618.9 Mn in 2021 and is forecast to reach a value of US$ 8,415.3 Mn by
2028 at a CAGR of 5.9% between 2022 and 2028 Global computed
tomography market is estimated
to be valued at US$ 7.9 Bn in 2023, and is expected to exhibit a CAGR of 6.5%
during the forecast period (2023-2030). Global positron
emission tomography (PET) scanners market is estimated to be valued at USD 2.41 Bn in 2024 and is expected
to reach USD 3.52 Bn by 2031, exhibiting a compound annual growth rate (CAGR)
of 5.6% from 2024 to 2031. The global brain monitoring
market was valued at US$ 3,170.4 Mn in 2021 and
is forecast to reach a value of US$ 5,092.7 Mn by 2028 at a CAGR of 7.1%
between 2022 and 2028
About Us: Coherent Market Insights is a global market intelligence and
consulting organization that provides syndicated research reports, customized
research reports, and consulting services. We are known for our actionable
insights and authentic reports in various domains including aerospace and
defense, agriculture, food and beverages, automotive, chemicals and materials,
and virtually all domains and an exhaustive list of sub-domains under the sun.
We create value for clients through our highly reliable and accurate reports.
We are also committed in playing a leading role in offering insights in various
sectors post-COVID-19 and continue to deliver measurable, sustainable results
for our clients. Contact Us: Mr. Shah Phone: US: +1-650-918-5898 UK: +44-020-8133-4027 AUS: +61-2-4786-0457 India: +91-848-285-0837 Email: sales@coherentmarketinsights.com 
Senior Client Partner – Business Development
Coherent Market Insights
